Clinical Trial Update: Fibrosis Lessens After Metabolic Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring metabolic surgery to reduce liver fibrosis in metabolic dysfunction-associated steatotic liver disease and related condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Fatty Liver Disease
• Obesity

Snippet

Sponsor: Ali Aminian | Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease | Phase 4 | Status: RECRUITING